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This population-based study in Hawaii collected cases of systemic 
lupus erythematosus from medical facilities and a patient support 
group. A total of 454 cases was found and the prevalence was 
estimated at 41.8 per 100,000 population for 1989. The prevalence 
odds ratio for all non-Caucasians compared to Caucasians was 
1.2 (0.9-1.5), for Japanese 1.3 (1.o-1. 7), for Filipinos 1.5 (1.1-2.0), 
forChinese2.4 (1.7-3.4), andforHawaiians0.8 (0.6-1.1). Mortality 
rates were 3 times higher for non-Caucasians than for Caucasians 
in 1985 to 1989. Despite the observed differences, it remains 
unclear whether individuals with Asian or Pacific Islander ancestry 
are at higher risk for systemic lupus erythematosus. The variation 
in prevalence rates may be a result of differences in access to 
medical care and in survival. 
Systemic lupus erythematosus (SLE) is an autoimmune disease 
of unknown etiology and most commonly SLE involves skin, 
joints, and kidneys. Because of the higher rates in women during 
their reproductive years,1 sex hormones are believed to have 
pathogenic importance. Genetic and environmental factors (in-
cluding viruses) are also suspected.2-4 
Reported ethnic differences in SLE prevalence may provide 
evidence for hereditary risk factors. Individuals of African5-10 
and Native American11 -12 descent are affected more often than 
Caucasians. While some studies have reported high prevalence 
rates among Chinese13 and other Asians, 14--16 a study fromJapan 17 
reports comparatively low prevalence rates (5 per 100,000). 
Evidence from New Zealand suggests higher rates for Polyne-
sians.18-19 Most population-based studies have reported preva-
lence rates of 40 to 50 cases per 100,000 population.20--22 Preva-
lence and incidence of SLE have slightly increased over the last 
40 years, probably because of earlier diagnosis, increased aware-
ness of SLE, and prolonged survival,23-25 
The multiethnic composition of Hawaii allows a unique op-
portunity for exploring possible ethnic differences in SLE 
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prevalence. Two hospital-based studies were performed on 
Oahu. Serdula26 estimated a prevalence rate of 14.6 per 100,000 
for 1975; Catalano27 a rate of 22.4 per 100,000 for 1980. Both 
studies concluded that prevalence rates for SLE were higher for 
Japanese, Hawaiians, Chinese, and Filipinos than for Cauca-
sians. Since many SLE patients never require hospitalization, 
the prevalence of SLE found in the hospital-based studies was 
probably an underestimate of the true prevalence. Also, hospi-
talization may have occurred preferentially for certain ethnic 
groups. Therefore, the current study was designed to estimate 
prevalence of SLE in Hawaii among the general population. 
Methods 
The diagnosis of SLE is based on criteria published by the 
American Rheumatism Association (ARA). 28 However, for the 
purposes of this study, any patient who had been given a 
diagnosis of SLE by a physician was considered a case. In 
TABLE 1 .-Demographic Characteristics of 
454 Systemic Lupus Erythematosus 
Patients in Hawaii, 1989. 
No. % 
Sex 
Male 53 12 
Female 401 88 
Ethnicity 
Chinese 46 10 
Filipino 63 14 
Hawaiian/Part Hawaiian 52 11 
Japanese 127 28 
Caucasian 97 21 
Others 69 15 
Age 
<20 years 41 9 
20-39 years 176 39 
40-59 years 174 38 
60 years and older 63 14 
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conversations with the physicians, many of whom were 
rheumatologists, it was ascertained that they applied the ARA 
criteria. Two SLE case-finding strategies were used: 
I. Five medical centers, 5 rheumatologists, 8 nephrologists, 
and 190 primary care physicians were contacted and asked for 
information on every case of SLE they had seen during 1988 and 
1989. Social Security Number (SSN), age, sex, zip code, and 
ethnicity were abstracted from the medical records. A one-page 
questionnaire requesting demographic and medical information 
was mailed to each patient whenever the physician/medical 
facility agreed. 
2. The Hawaii Lupus Foundation, a state-wide patient support 
group, sent a copy of the questionnaire to all500 individuals on 
their mailing list. 
Data on cases obtained from both sources were entered into a 
computerized data base and duplicates were eliminated by 
matching for SSN. Prevalence rates were calculated using 
population estimates by age, sex, and ethnicity for 1989 from the 
Hawaii Health Surveillance Program (an unpublished report). 
Ethnicity information from this annual household survey is 
considered more reliable than census information because the 
ethnic categories used in the census are inappropriate for Hawaii's 
ethnically diverse population, especially because of the many 
children from mixed marriages. Six categories of ethnicity 
(Hawaiian, Japanese, Chinese, Caucasian, Filipino, other) were 
used for classification. Individuals with any percentage of 
Hawaiian ancestry were classified as Hawaiians. The category 
"other" includes individuals with mixed non-Hawaiian, un-
known, and other ancestries. 
A model with prevalence rates for SLE as the dependent 
variable, and sex, age, and ethnicity as independent variables, 
was constructed using logistic regression.29 All deaths coded 
710.0 (ICD-9) systemic lupus erythematosus were obtained 
from the state records of deaths for 1985 to 1989 and age-
adjusted mortality rates were calculated. Statistical analysis was 
performed using the SAS® software package. 30 
Results 
Altogether 588 cases of SLE were identified: 206 through 
rheumatologists and nephrologists, 159 through hospital records, 
56 through primary care physicians, 46 through the Pediatric 
Arthritis Center, and 121 through the Lupus Foundation. After 
deleting duplicates, 454 prevalent cases remained, giving an 
estimated SLE prevalence rate of 41.8 per 100,000 population in 
1989. 
The cases are predominantly women and distributed across all 
ethnic groups (Table 1 ). Prevalence rates vary by sex, age, and 
ethnicity (Tables 2 and 3). Results of the logistic regression 
(Table 4) show statistically significant increased SLE preva-
lence odds ratio for individuals of Chinese and Filipino ancestry 
when compared to Caucasians. Observed differences for the 
other ethnic groups failed to demonstrate statistical signifi-
cance. Rates of all non-Caucasians compared to Caucasians 
were insignificantly higher. 
Seven hundred sixteen questionnaires were mailed: 500 to 
members of the Lupus Foundation and 216 to patients identified 
through medical records. One hundred thirty (26%) of the 
former and 87 ( 40%). of the latter were returned. Of the 217 
returned questionnaires, 199 were usable for analysis, reflecting 
78 cases identified through the medical system only, 73 identi-
TABLE 2.-Estimated Prevalence of Systemic Lupus Erythematosus among Females, Hawaii, 1989. 
Rates are per 1 00,000 population. 
Total Chinese Filipino Hawaiian/ Japanese Others Cauca- Non-
Part sian Cauca-Age 
Hawaiian sian 
No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
---------------------------------------------------------------------------------------------------------
<20 33 20 4 93 10 67 6 13 3 18 8 
20-39 161 91 17 244 33 173 20 68 35 109 30 
40-59 150 127 11 172 14 98 14 78 50 149 20 
60+ 57 70 7 98 3 38 5 69 18 49 7 
All 401 74 39 157 60 107 45 44 106 88 65 
Age-
adj.• 74 161 104 53 81 
• Age adjusted by the direct method to the total population of Hawaii, 1989. 
-
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16 2 7 31 23 
77 26 51 135 106 
115 41 146 109 121 
80 17 133 40 59 
57 86 71 315 76 
68 71 78 
fied though the Lupus Foundation only, and 48 cases identified 
by both. Forty percent of cases had never been hospitalized 
because of SLE, 49% had been hospitalized l to 9 times, and 
11% more than 9 times. Among the patients who had never been 
hospitalized, 35% were Caucasian, whereas only 12% of those 
who had been hospitalized at least once were Caucasian. For 
Caucasians the mean number of hospitalizations related to SLE 
was 1, and for all others it was 2.7. SLE patients identified 
through the Lupus Foundation differed in almost all character-
istics from the cases identified through medical records (Table 
5). SLE Mortality rates were low for all ethnic groups, but 3 
times higher for non-Caucasians than Caucasians (Table 6). 
Discussion 
The prevalence rate of 41.8 per 100,000 is consistent with other 
reports.9•20-21 Nevertheless, it probably underestimates the true 
prevalence rate. Patients suffering from a mild form ofSLE, who 
have infrequent contact with the medical system or who are 
treated by primary care physicians in rural areas, could have 
been missed in this study. The fact that 60% of the foundation 
members were not located through the medical system suggests 
either that a considerable number ofSLE patients may have been 
missed or that these members were not true cases. If a propor-
tionate number of patients who are not members of the Founda-
tion were missed, there could be as many as 950 SLE patients in 
the state or nearly 90 per 100,000 population. For many reasons, 
that appears unlikely. However, some self- reported diagnoses 
may not have been confirmed cases of SLE. If only cases 
identified through medical records were considered prevalent 
cases, the estimated prevalence rate becomes 36.2 per 100,000, 
still much higher than reported in both previous studies. 
A major shortcoming of this study lies in its reliance on 
physician diagnosis rather than the ARA diagnostic criteria. 
However, 365 out of 454 (80%) cases were identified through 
rheumatologists, nephrologists, and hospitals. Based on conver-
sations with many of these physicians, the authors feel confident 
that the ARA criteria had been applied by these specialists. 
Therefore, ascertainment bias should be fairly small. 
Although access to medical care is estimated to be above 95% 
in Hawaii,31 Hawaiians and Filipinos, who form a larger part of 
the population in rural parts of the islands, were more likely to 
be missed during the case-finding process. Therefore, the preva-
lence rates for these ethnic groups are probably underestimates. 
Low health care utilization among Hawaiians may also have 
resulted in higher mortality due to SLE and lower prevalence of 
SLE. The rate for Chinese is less stable because of the relatively 
small Chinese population. 
Compared to both earlier Hawaii hospital-based studies,26•27 
the two- to threefold higher prevalence rate in 1989 can be 
explained by the inclusion of SLE patients who never had been 
hospitalized. Forty percent of SLE patients in this study had 
never required hospital care. Caucasians experiencing fewer 
hospitalizations could explain the large ethnic differences found 
in the earlier studies. The results of this study differ from the 
earlier findings of a statistically significant increased prevalence 
rate for non-Caucasians. It has been documented that Cauca-
sians have a later onset and a milder course than other ethnic 
groups.32 The threefold increased SLE-related mortality for 
non-Caucasians in this study supports that finding. On the other 
hand, the differences in mortality could be a result of differences 
in medical care. Since Serdula's study,26 the mortality rate for 
non-Caucasians has decreased by 50%, possibly a result of 
improved medical care. 
Since prevalence is a result of both incidence and mortality, 
cross-sectional studies do not allow direct risk measurement; 
hence risk inference must be interpreted with caution. Although 
TABLE 3.-Estimated Prevalence of Systemic Lupus Erythematosus among Males, Hawaii, 1989. 
Rates are per 100,000 population. 




No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate No. Rete No. Rate 
--------------------------------------------------------------------------------------------------------
-
<20 8 5 0 0 2 11 2 4 6 
20-39 15 8 2 36 6 4 12 6 18 
40-59 24 21 4 59 0 0 6 11 36 
60+ 6 8 19 0 0 0 0 3 10 
All 53 10 7 34 3 5 7 7 21 19 
Age-
adj.* 10 27 5 7 17 
* Aye adjusted by the direct method to the total population of Hawaii, 1989. 
-
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2 4 3 7 5 
2 2 14 11 
6 7 22 17 21 
0 0 2 15 4 6 
4 3 11 8 42 10 
3 8 10 
significant differences between Caucasians and certain Asian 
ethnic groups (Chinese and Filipino) were observed, this differ-
ence in prevalence may not be a result of an increased risk for 
SLE but it could be from differences in medical care, diagnosis, 
and mortality. 
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TABLE 5.-Comparison of Questionnaire Data 
for SLE Patients in Hawaii, 1989. 
A.-Recruited through medical system 
B.-Recruited through medical system and Lupus Foundation 
C.-Recruited through Lupus Foundation only 
A B c 
Number of cases 78 48 73 
Mean age in 1989 (years) 38 34 48 
Mean age at onset (years) 27 22 29 
Mean age at diagnosis (yearst 29 25 37 
Oahu residents (%) 80 83 95 
Proportion Caucasian (%) 6 17 37 
Proportion Filipino (%) 18 17 4 
Proportion Japanese(%) 38 25 23 
Skin disease (%) 56 68 71 
Kidney disease(%) 62 53 30 
Joint disease(%) 91 81 80 
Hospitalizations for SLE 3 2.5 1.6 
Morbidity (days during last year) 58 46 46 
Born in Hawaii (%) 83 69 63 
TABLE 6.-Age-specific Death Rates for 
SLE in Hawaii, 1985 to 1989. 
Rates are per million population per year. 
Caucasians Non-Caucasians 
Age 
No. Rate No. Rate 
0-19 years 0 0 3 2.1 
20-39 years 1.9 10 8.1 
40-59 years 3.8 8 9.6 
60+ years 6.3 9 15.6 
Total 3 2.4 30 7.5 
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